Melanie Tichet

Lausanne Branch
Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A new effLuc/Kate dual reporter allele for tumor imaging in mice.

A new effLuc/Kate dual reporter allele for tumor imaging in mice.

Journal: Disease models & mechanisms

Published: September 30, 2024

Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion.

Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion.

Journal: Science (New York, N.Y.)

Published: November 17, 2022

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages.

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages.

Journal: Immunity

Published: March 04, 2022

Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity.

Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity.

Journal: Cancer cell

Published: November 03, 2021

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.

Journal: Nature

Published: March 14, 2021

Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Journal: Cancer immunology research

Published: May 01, 2019

ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.

ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.

Journal: Developmental cell

Published: June 06, 2018

Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway.

Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway.

Journal: Oncogene

Published: May 25, 2018

Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice.

Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice.

Journal: Cancer immunology research

Published: March 15, 2018

Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.

Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.

Journal: Molecular cancer therapeutics

Published: September 18, 2017

Cellular endogenous NAD(P)H fluorescence as a label-free method for the identification of erythrocytes and reticulocytes.

Cellular endogenous NAD(P)H fluorescence as a label-free method for the identification of erythrocytes and reticulocytes.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: January 16, 2017

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.

Journal: Cancer research

Published: June 08, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026